05:47 PM EST, 12/12/2024 (MT Newswires) -- Justin Chakma, Chief Business Officer, on December 10, 2024, sold 50,000 shares in Ars Pharmaceuticals ( SPRY ) for $657,625. Following the Form 4 filing with the SEC, Chakma has control over a total of 136,380 shares of the company, with 136,380 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000141588924029162/xslF345X05/form4-12122024_101220.xml